跳至主要内容
临床试验/NL-OMON52091
NL-OMON52091尚未招募不适用

In vivo effects of amylase trypsin inhibitors from wheat in the human gut: proof of cause of non-coeliac wheat sensitivity in irritable bowel syndrome? - In vivo effects of amylase trypsin inhibitors (ATI study)

niversiteit Maastricht0 个研究点目标入组 8 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
8

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • 1) No gastrointestinal complaints and/or disease
  • 2) Age between 18-65 years
  • 3) BMI between 20-30 kg/m2

排除标准

  • 1) History of severe cardiovascular, respiratory, urogenital,
  • gastrointestinal/hepatic, hematological/immunologic, HEENT (head, ears, eyes,
  • nose, throat), dermatological/connective tissue, musculoskeletal,
  • metabolic/nutritional, endocrine, neurological/psychiatric diseases, allergy,
  • major surgery and/or laboratory assessments which might limit participation in
  • or completion of the study protocol.
  • 2) Use of medication, including nutritional supplements, except oral
  • contraceptives, within 14 days prior to testing.
  • 3) Administration of investigational drugs or participation in any scientific
  • intervention study, which may interfere with this study (to be decided by the
  • principal investigator), in the 180 days prior to the study.
  • 4) Major abdominal surgery interfering with gastrointestinal function.
  • 5) Pregnancy, lactation.
  • 6) Excessive alcohol consumption, smoking, drug use.
  • 7) Blood donation within 3 months before or after the study period.
  • 8) Plan to lose weight or follow a specific diet within the study period.

研究者

相似试验